The product
The PARI eFlow® electronic nebuliser. It enables liquid medication to be inhaled through the lungs with as much as 90% efficiency.

TTP’s role

In partnership with PARI GmbH – a worldwide leader in efficient aerosol delivery and pharmaceutical formulation development – TTP’s proprietary electronic atomiser technology, TouchSpray™ was developed to create an innovative inhalation system for treatment of respiratory diseases.

What makes it different?

  • Reduces treatment time by more than 50%
  • Silent, discreet operation
  • Battery-powered and easily portable
  • Interchangeable spray heads allow easy cleaning
  • More reliable and serviceable than traditional compressor-based systems
  • Designed for use with all inhalation medications approved in Europe